Brussels, March 6^th 2006 – DNAVision laboratory from BioVallée, announced today that it has obtained ISO/IEC 17025 accreditation by BELAC. DNAVision is the first full-service pharmacogenetic / pharmacogenomic DNA testing laboratory to receive this accreditation in the world.

ISO 17025 is an international standard that assesses the technical competency of analytical laboratories and helps to ensure accurate data generation, controlled test methods and procedures, and properly trained personnel. ISO 17025 covers every aspect of laboratory management, including sample preparation, analytical testing proficiency, report generation and record keeping.

“DNAVision is proud to be the first full-service European pharmacogenomic DNA testing laboratory to reach this globally-recognized accreditation. We are now in a new era where pharmacogenomic analytical data needs the highest quality requirements” said Jean-Pol Detiffe, business director of DNAVision laboratory. “Our success in meeting the stringent standards for this ISO designation reflects our ongoing efforts to ensure unsurpassed consistency in our procedures and the accuracy of our results.”

Our accreditation scope includes different analytical methods:

-         expression profiling (Affymetrix, …)

-         SNP genotyping

-         DNA sequencing

-         other tests in the field of food quality, animal diagnostic, …

About DNAVision

DNAVision is a leading provider of applied pharmacogenetic & pharmacogenomic services.

DNAVision offers the powerful combination of different technologies in expression profiling, SNP genotyping and sequencing in a high quality environment. DNAVision is a spin-off of BioVallée, University of Brussels and Institute of Pathology and Genetics. More information on DNAVision’s service portfolio can be found on www.dnavision.be

Further information:

Jean-Pol Detiffe

BioVallée DNAVision LAB

Tel. +32 71 378 527

Fax. +32 71 378 501

jp.detiffe@dnavision.be